CYTODYN INC (CYDY:OTCMKTS)
$0.374 0.016 (4.4693%)
Analysed CYTODYN INC (CYDY:OTCMKTS) News Sources
CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study
21-04-2026
yahoo.com
CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026
20-04-2026
yahoo.com
CytoDyn to Present at the AACR Annual Meeting 2026
14-04-2026
yahoo.com
CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer
24-03-2026
yahoo.com
CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab
05-03-2026
yahoo.com
Creatv Bio's LifeTracDx® Blood Test Utilized as Exploratory Biomarker in CytoDyn's Phase 2 Study in Patients with Relapsed/Refractory Metastatic Colorectal Cancer
03-03-2026
yahoo.com
CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference
20-02-2026
yahoo.com
CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer
27-01-2026
yahoo.com
December 2025 Letter to Shareholders
16-12-2025
yahoo.com
CytoDyn to Showcase PD-L1 Upregulation and Improved Survival in Metastatic Triple Negative Breast Cancer at the San Antonio Breast Cancer Symposium
08-12-2025
yahoo.com
What is the current price of CYTODYN INC (CYDY:OTCMKTS)?
The current price of CYTODYN INC (CYDY:OTCMKTS) is $0.374.
CYTODYN INC (CYDY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of CYTODYN INC (CYDY:OTCMKTS) since the previous trading day is $0.016.
CYTODYN INC (CYDY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of CYTODYN INC (CYDY:OTCMKTS) since the previous trading day is 4.4693%.
What is the most recent average sentiment score for CYTODYN INC (CYDY:OTCMKTS)?
The most recent average sentiment score for CYTODYN INC (CYDY:OTCMKTS) is 81 out of 100.
What is the most recent average sentiment for CYTODYN INC (CYDY:OTCMKTS)?
The most recent sentiment for CYTODYN INC (CYDY:OTCMKTS) is .
SEC-8K** Filing Available For CYTODYN INC (CYDY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.